Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2026 = ×
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


An overall contraction in Return on Equity (ROE) is evident over the analyzed period, declining from 17.36% in March 2022 to 11.94% by March 2026. This downward trajectory is primarily driven by a deterioration in asset profitability, as the company's financial leverage remained relatively stable and failed to offset the decline in operational efficiency.

Return on Equity (ROE)
ROE exhibited a consistent long-term decline, characterized by a gradual decrease between March 2022 and December 2023, followed by a more pronounced drop starting in 2024. The most significant contraction occurred between December 2023 (15.23%) and June 2025 (12.26%), representing a substantial erosion of shareholder returns.
Return on Assets (ROA)
ROA serves as the primary driver for the observed decline in ROE. Starting at 6.21% in March 2022, ROA experienced a steady decline, falling below the 5.0% threshold by March 2025 and reaching a period low of 4.17% by March 2026. This pattern indicates a reduction in the company's ability to generate profit from its total asset base.
Financial Leverage
Financial leverage remained remarkably stable throughout the period, fluctuating within a narrow range between a low of 2.66 in September 2024 and a high of 2.92 in March 2023. Because leverage did not increase to compensate for falling asset returns, it played a neutral role in the overall decline of equity returns.
DuPont Component Correlation
The disaggregation of ROE reveals that the volatility and downward trend in equity returns are almost exclusively attributable to the ROA component. The lack of significant movement in the financial leverage ratio confirms that the decline in ROE is a result of diminishing operational profitability or asset efficiency rather than changes in the capital structure.

Three-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2026 = × ×
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) exhibits a sustained downward trajectory over the analyzed period, declining from 17.36% in March 2022 to 11.94% by March 2026. This contraction reflects a systemic reduction in the company's ability to generate profit from shareholders' equity, driven primarily by a significant decline in profit margins that outweighed marginal improvements in asset efficiency and stable leverage levels.

Net Profit Margin
A consistent and pronounced decline is observed in the net profit margin, which fell from 4.37% in March 2022 to 2.64% in March 2026. The most significant erosion occurred between December 2023 and June 2025, where margins dropped from 3.52% to 2.85%. This steady compression indicates that rising operational costs or pricing pressures have fundamentally impaired the company's profitability per unit of revenue.
Asset Turnover
Asset turnover demonstrated a general upward trend, increasing from 1.42 in March 2022 to 1.58 in March 2026, with a peak of 1.63 in December 2025. This improvement suggests an increase in operational efficiency and a better capacity to utilize the asset base to generate sales. However, these gains were insufficient to counteract the negative impact of the shrinking profit margins on the overall ROE.
Financial Leverage
Financial leverage remained relatively stable throughout the period, fluctuating within a narrow range between a low of 2.66 in September 2024 and a high of 2.92 in March 2023. The closing value of 2.87 in March 2026 is closely aligned with the starting value of 2.79. This stability indicates that the decline in ROE was not a result of deleveraging or changes in the capital structure, but rather a consequence of operational performance.

In summary, the DuPont disaggregation reveals that the erosion of ROE is almost exclusively driven by the deterioration of the net profit margin. While the company successfully improved its asset turnover, the magnitude of the margin compression was the dominant factor in the overall decline of equity returns.


Five-Component Disaggregation of ROE

Elevance Health Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2026 = × × × ×
Dec 31, 2025 = × × × ×
Sep 30, 2025 = × × × ×
Jun 30, 2025 = × × × ×
Mar 31, 2025 = × × × ×
Dec 31, 2024 = × × × ×
Sep 30, 2024 = × × × ×
Jun 30, 2024 = × × × ×
Mar 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Sep 30, 2023 = × × × ×
Jun 30, 2023 = × × × ×
Mar 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Sep 30, 2022 = × × × ×
Jun 30, 2022 = × × × ×
Mar 31, 2022 = × × × ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Equity (ROE) exhibits a sustained downward trajectory, declining from 17.36% in March 2022 to 11.94% by March 2026. This erosion in shareholder returns is primarily attributable to a significant contraction in operating profitability and a rising interest burden, which together outweigh marginal improvements in asset utilization and tax efficiency.

Operating Profitability (EBIT Margin)
A consistent and pronounced decline in the EBIT margin is observed, falling from 6.24% in early 2022 to 3.85% by March 2026. This trend represents the most significant negative contributor to the overall reduction in ROE, suggesting a steady increase in operating expenses relative to revenue over the period.
Financial Cost (Interest Burden)
The interest burden ratio has trended downward from 0.91 to 0.81. This persistent decline indicates that a larger portion of operating income is being consumed by interest payments, further compressing the net profit margin.
Asset Efficiency (Asset Turnover)
Asset turnover generally demonstrates an upward trend, rising from 1.42 in March 2022 to a peak of 1.63 in December 2025 before settling at 1.58 in March 2026. While this indicates improved efficiency in generating revenue from the asset base, these gains were insufficient to counteract the declines in operating and financial margins.
Tax Efficiency (Tax Burden)
The tax burden remained relatively stable around 0.77 for the first several quarters before dipping to 0.76 in 2024 and subsequently increasing to 0.84 by late 2025. The recent increase suggests a higher proportion of pre-tax income is being retained, providing a slight positive offset to the overall ROE decline in the final periods.
Financial Leverage
Financial leverage has remained relatively stable, fluctuating within a range between 2.66 and 2.92. The absence of a significant upward trend in leverage indicates that the company has not utilized increased debt to amplify returns in the face of falling margins.

Two-Component Disaggregation of ROA

Elevance Health Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2026 = ×
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Assets (ROA) exhibits a persistent downward trajectory over the analyzed period, decreasing from 6.21% in March 2022 to 4.17% by March 2026. This decline indicates a reduction in the overall efficiency of the asset base in generating net income, resulting from a divergence between profitability margins and asset utilization.

Net Profit Margin
A consistent contraction in net profit margins is observed, falling from 4.37% in March 2022 to 2.64% in March 2026. While the decline was gradual through 2022, a more pronounced erosion occurred between December 2023 (3.52%) and March 2026, suggesting an increasing pressure on bottom-line profitability relative to revenue generation.
Asset Turnover
In contrast to the profitability trend, asset turnover generally improved, rising from 1.42 in March 2022 to a peak of 1.63 in December 2025, before ending at 1.58 in March 2026. This upward movement indicates an enhanced ability to generate sales from the company's assets, reflecting an improvement in operational throughput.
Drivers of ROA Variance
The disaggregation of ROA reveals that the increase in asset turnover was insufficient to offset the decline in net profit margin. The positive impact of improved asset efficiency was overwhelmed by the significant compression of margins, which acted as the primary driver for the overall decline in ROA. The data suggests that while the company became more efficient at utilizing its assets to drive volume, it became less effective at converting those sales into net profit.

Four-Component Disaggregation of ROA

Elevance Health Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2026 = × × ×
Dec 31, 2025 = × × ×
Sep 30, 2025 = × × ×
Jun 30, 2025 = × × ×
Mar 31, 2025 = × × ×
Dec 31, 2024 = × × ×
Sep 30, 2024 = × × ×
Jun 30, 2024 = × × ×
Mar 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Sep 30, 2023 = × × ×
Jun 30, 2023 = × × ×
Mar 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Sep 30, 2022 = × × ×
Jun 30, 2022 = × × ×
Mar 31, 2022 = × × ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Assets (ROA) exhibits a general downward trajectory over the analyzed period, declining from 6.21% in March 2022 to 4.17% by March 2026. While there was a brief period of recovery in mid-2024, the long-term trend indicates a erosion of overall asset profitability driven primarily by operating margin compression and rising financial costs.

EBIT Margin
A consistent and significant contraction in the EBIT margin is observed, falling from 6.24% in the first quarter of 2022 to 3.85% by the first quarter of 2026. This steady decline represents the primary driver of the reduction in ROA, suggesting a decrease in operational efficiency or an increase in operating expenses relative to revenue generation.
Asset Turnover
In contrast to the margin decline, asset turnover generally improved over the period. The ratio increased from 1.42 in March 2022 to a peak of 1.63 in December 2025, before settling at 1.58 in March 2026. This upward trend indicates an increase in the efficiency of asset utilization to generate sales, which served as a partial hedge against the falling EBIT margins.
Interest Burden
The interest burden shows a continuous decline, moving from 0.91 in early 2022 to 0.81 by March 2026. This downward movement signifies that a larger portion of operating income is being consumed by interest expenses, reflecting an increase in the company's financial leverage or higher borrowing costs over time.
Tax Burden
The tax burden remained remarkably stable between 0.76 and 0.78 for the majority of the period. However, a notable increase to 0.84 occurred between December 2025 and March 2026. This shift indicates a lower effective tax rate relative to pre-tax income during the final quarters, which provided a late-stage modest support to the ROA.

The disaggregated analysis reveals a conflict between operational efficiency and asset productivity. While the company successfully improved its asset turnover ratio, these gains were insufficient to offset the combined negative impact of shrinking EBIT margins and a deteriorating interest burden. The overall decline in ROA is therefore characterized as an operational and financial cost issue rather than a failure of asset utilization.


Disaggregation of Net Profit Margin

Elevance Health Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2026 = × ×
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


A consistent decline in overall profitability is evident over the analyzed period, with the net profit margin contracting from 4.37% in March 2022 to 2.64% by March 2026. This erosion in the bottom line is primarily attributable to a significant compression in operating efficiency, though it is further influenced by shifting financing costs and tax dynamics.

EBIT Margin
The operating margin exhibits a persistent downward trajectory, falling from a peak of 6.24% in March 2022 to 3.85% in March 2026. While a temporary recovery to 5.66% was observed in June 2024, the subsequent trend has been sharply negative, indicating that increasing operational costs or pricing pressures have fundamentally diminished the ability to generate earnings before interest and taxes.
Interest Burden
The interest burden ratio has steadily decreased from 0.91 in early 2022 to 0.81 by March 2026. This downward trend indicates that interest expenses are consuming an increasing proportion of operating income, suggesting a growing impact of debt servicing costs on the final net margin.
Tax Burden
The tax burden remained highly stable at approximately 0.77 to 0.78 for the majority of the period. However, a notable increase to 0.84 occurred between December 2025 and March 2026. This increase implies a reduction in the effective tax rate during the final quarters, which provided a marginal buffer against the broader decline in profitability.
Net Profit Margin
The net profit margin reflects the aggregate effect of the aforementioned components. The primary driver of the decline is the substantial contraction of the EBIT margin. The negative pressure from the worsening interest burden further eroded the margin, and while the improvement in the tax burden toward the end of the period provided slight relief, it was insufficient to reverse the overall downward trend.